BioCentury
ARTICLE | Company News

Interprotein, Ipsen deal

November 23, 2015 8:00 AM UTC

Ipsen and Interprotein partnered to develop therapeutic peptides to treat endocrine diseases, including Cushing’s disease. Ipsen will have an exclusive option to license candidates developed during th...